NCT05564390 2026-03-18
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
74 trialsNCT01042379 2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT07023289 2026-03-13
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
AbbVie
Phase 2 Recruiting
NCT06528990 2026-03-05
Telehealth Intervention for Ostomy Self-Management
City of Hope Medical Center
Phase 2 Recruiting
NCT05681039 2026-03-02
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT02645149 2026-02-27
Match Mel
Melanoma Institute Australia
Phase 2 Completed
NCT03808337 2026-02-27
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT04602533 2026-02-27
Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
Johannes Gutenberg University Mainz
Phase 2 Active not recruiting
NCT06995508 2026-02-17
Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial
Roswell Park Cancer Institute
Phase 2 Recruiting
NCT04485949 2026-02-10
A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
Imvax
Phase 2 Active not recruiting
NCT07250477 2026-02-09
Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer
University of California, Davis
Phase 2 Recruiting
NCT03808662 2026-02-04
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06532279 2026-02-02
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NRG Oncology
Phase 2 Recruiting
NCT07346209 2026-01-16
STRIPe
University of California, San Diego
Phase 2 Not yet recruiting
NCT07337447 2026-01-13
REWENEC 01
Hospices Civils de Lyon
Phase 2 Not yet recruiting
NCT03844620 2026-01-09
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06861244 2026-01-07
PNOC031
University of California, San Francisco
Phase 2 Recruiting
NCT03599765 2025-12-31
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05503251 2025-12-24
Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT03745794 2025-12-23
Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00929214 2025-12-17
Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01723774 2025-12-09
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Washington University School of Medicine
Phase 2 Active not recruiting
NCT07087860 2025-12-09
RECIPE-B1
Mayo Clinic
Phase 2 Recruiting
NCT07254962 2025-11-28
CAPTURE
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2 Not yet recruiting
NCT05704829 2025-11-19
ADAPTHER2-IV
West German Study Group
Phase 2 Active not recruiting
NCT05454488 2025-11-14
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT00877500 2025-11-10
Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06014255 2025-10-29
HEAT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT05077072 2025-10-20
Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04567420 2025-10-16
DARE
Criterium, Inc.
Phase 2 Recruiting
NCT04870762 2025-10-08
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06052826 2025-10-06
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
City of Hope Medical Center
Phase 2 Recruiting
NCT03075423 2025-09-26
Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC
Goethe University
Phase 2 Completed
NCT05877521 2025-09-23
Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04067830 2025-09-05
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Roswell Park Cancer Institute
Phase 2 Recruiting
NCT06057675 2025-08-19
Tranexamic Acid in Nasal Mohs Reconstruction
Vanderbilt University Medical Center
Phase 2 Recruiting
NCT06401980 2025-08-14
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Swiss Cancer Institute
Phase 2 Recruiting
NCT06559228 2025-06-15
ConnectedNest: a Digital Platform Connecting Individuals With Cancer to Social Care
University of Minnesota
Phase 2 Recruiting
NCT06562348 2025-05-01
ctDNA-RECIST
Aarhus University Hospital
Phase 2 Recruiting
NCT03763253 2025-02-07
IP2-ATLANTA
Imperial College London
Phase 2 Active not recruiting
NCT04724928 2025-01-15
EFFORT-MIBC
University Hospital, Ghent
Phase 2 Recruiting
NCT03395587 2024-12-02
GlioVax
Heinrich-Heine University, Duesseldorf
Phase 2 Active not recruiting
NCT03217071 2024-10-23
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer
University of California, San Francisco
Phase 2 Completed
NCT06636682 2024-10-21
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Cellvax Therapeutics Inc
Phase 2 Recruiting
NCT04680260 2024-08-14
OPTIMISE
Aarhus University Hospital
Phase 2 Recruiting
NCT06470880 2024-06-24
DyNAMIc
The Christie NHS Foundation Trust
Phase 2 Not yet recruiting
NCT05045443 2024-01-08
CurcumPedALL
Ain Shams University
Phase 2 Completed
NCT04496219 2024-01-02
Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT04405401 2023-12-12
SUPPRESS-NSCLC
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2 Recruiting
NCT03088059 2023-11-03
UPSTREAM
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Unknown